Hinge Health, Inc.
HNGE
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.96B
Close$
$22.01
79% downside
Current Fair Value
79% downsideOvervalued by 79% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.96 Billion |
|---|---|
| Enterprise Value | $8.10 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.36 |
| Beta | 1.36 |
| Outstanding Shares | 78,795,000 |
Return
| Return on Equity | 31.68% |
|---|---|
| Return on Assets | 13.18% |
| Return on Invested Capital | 28.58% |
Valuation & Multiples
| P/E Ratio | 76.41 |
|---|---|
| PEG | -71.02 |
| Price to Sales | 11.66 |
| Price to Book Ratio | 26.24 |
| Enterprise Value to Revenue | 11.25 |
| Enterprise Value to EBIT | 81.91 |
| Enterprise Value to Net Income | 74 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 1.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.61
Average shareholder expectationRevenue Estimate
$201.46 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$0.60
Average shareholder expectationRevenue Estimate
$224.71 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hinge Health, Inc.
1,437 employees
CEO: Daniel A. Perez Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage ...